{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:31:37Z","timestamp":1784543497723,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017055","name":"National Natural Science Foundation of China-Shandong Joint Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bioorg.2021.104648","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T01:19:53Z","timestamp":1610500793000},"page":"104648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties"],"prefix":"10.1016","volume":"108","author":[{"given":"Bo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuju","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.104648_b0005","unstructured":"http:\/\/www.diabetesatlas.org\/."},{"key":"10.1016\/j.bioorg.2021.104648_b0010","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1016\/S0021-9258(18)68702-2","article-title":"Purification of the major protein-tyrosine-phosphatases of human placenta","volume":"263","author":"Tonks","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0015","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1074\/jbc.271.33.19810","article-title":"Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling","volume":"271","author":"Kenner","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1006868409841","article-title":"Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction","volume":"182","author":"Byon","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2021.104648_b0025","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2021.104648_b0030","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.275.13.9792","article-title":"Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on \u201csubstrate-trapping\u201d mutants","volume":"275","author":"Walchli","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng1963","article-title":"Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis","volume":"39","author":"Julien","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bioorg.2021.104648_b0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2012.03.066","article-title":"Down-regulated expression of the protein-tyrosine phosphatase 1B (PTP1B) is associated with aggressive clinicopathologic features and poor prognosis in hepatocellular carcinoma","volume":"420","author":"Zheng","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2021.104648_b0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/acschembio.5b00506","article-title":"Interrogating endogenous protein phosphatase activity with rationally designed chemosensors","volume":"11","author":"Beck","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2021.104648_b0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cbpa.2009.03.021","article-title":"The therapeutic potential of phosphatase inhibitors","volume":"13","author":"Vintonyak","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2021.104648_b0055","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/oby.2009.444","article-title":"Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice","volume":"18","author":"Lantz","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bioorg.2021.104648_b0060","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1021\/jm901090b","article-title":"Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer","volume":"53","author":"Combs","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0065","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2174\/0929867311320210001","article-title":"Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus","volume":"20","author":"Panzhinskiy","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejmech.2017.12.064","article-title":"Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site","volume":"144","author":"Du","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ejmech.2018.12.032","article-title":"Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors","volume":"164","author":"Xie","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103221","article-title":"Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors","volume":"92","author":"Maheshwari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0085","doi-asserted-by":"crossref","first-page":"13624","DOI":"10.1021\/acs.jafc.9b06155","article-title":"Identification of cyanidin-3-arabinoside extracted from blueberry as a selective protein tyrosine phosphatase 1B inhibitor","volume":"67","author":"Tian","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/np5005856","article-title":"Insulin-mimetic selaginellins from Selaginella tamariscina with protein tyrosine phosphatase 1B (PTP1B) inhibitory activity","volume":"78","author":"Nguyen","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2021.104648_b0095","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1021\/acs.orglett.7b02633","article-title":"Rhodomollacetals A-C, PTP1B Inhibitory Diterpenoids with a 2,3:5,6-Di-seco-grayanane Skeleton from the Leaves of Rhododendron molle","volume":"19","author":"Zhou","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2021.104648_b0100","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1021\/acs.biochem.9b00499","article-title":"An isoform-selective PTP1B inhibitor derived from nitrogen-atom augmentation of radicicol","volume":"58","author":"Shi","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2021.104648_b0105","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/acs.jafc.7b01353","article-title":"Potential of Polygonum cuspidatum root as an antidiabetic food: dual high-resolution alpha-glucosidase and PTP1B inhibition profiling combined with HPLC-HRMS and NMR for identification of antidiabetic constituents","volume":"65","author":"Zhao","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejmech.2019.02.034","article-title":"Shooting three inflammatory targets with a single bullet: novel multi-targeting anti-inflammatory glitazones","volume":"167","author":"Elzahhar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmech.2015.12.049","article-title":"Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARgamma\/FFAR1 dual agonists","volume":"109","author":"Darwish","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.biopha.2016.08.036","article-title":"Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: synthesis, biological evaluations and molecular docking study","volume":"83","author":"Khan","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2021.104648_b0125","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1021\/acs.jmedchem.8b00610","article-title":"Tau-centric multitarget approach for Alzheimer's disease: development of first-in-class dual glycogen synthase kinase 3beta and tau-aggregation inhibitors","volume":"61","author":"Gandini","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0130","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/S0140-6736(00)04960-6","article-title":"Lessons from the glitazones: a story of drug development","volume":"357","author":"Gale","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2021.104648_b0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/np020528c","article-title":"Bromophenols from the Red Alga Rhodomela confervoides","volume":"66","author":"Fan","year":"2003","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2021.104648_b0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2013.03.037","article-title":"Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL\/KsJ-db\/db mice","volume":"64","author":"Jiang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bmc.2012.10.053","article-title":"Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin","volume":"21","author":"Handzlik","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0150","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0968-0896(01)00366-2","article-title":"Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones","volume":"10","author":"Bruno","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm800937p","article-title":"Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases","volume":"52","author":"Xia","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0160","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2174\/1389557511313110006","article-title":"Diphenylether derivative as selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) over t-cell protein tyrosine phosphatase (TCPTP) identified through virtual screening","volume":"13","author":"Reddy","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104648_b0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.104648_b0170","first-page":"150","article-title":"Dyslipidemia in type 2 diabetes mellitus","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2021.104648_b0175","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/sj.onc.1209100","article-title":"AKT signaling in normal and malignant cells","volume":"24","author":"Testa","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2021.104648_b0180","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrd.2016.151","article-title":"Targeting hepatic glucose metabolism in the treatment of type 2 diabetes","volume":"15","author":"Rines","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.104648_b0185","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1021\/acs.molpharmaceut.8b01106","article-title":"Highly selective protein tyrosine phosphatase inhibitor, 2,2\u2032,3,3\u2032-tetrabromo-4,4\u2032,5,5\u2032-tetrahydroxydiphenylmethane, ameliorates type 2 diabetes mellitus in BKS db mice","volume":"16","author":"Li","year":"2019","journal-title":"Mol. Pharm."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:10:36Z","timestamp":1758615036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":37,"alternative-id":["S0045206821000249"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104648","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104648"}}